Data Insights
Artificial Intelligence (10)
Big Data (4)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (13)
Chemotherapy (1)
Cloud (1)
Corporate Governance (3)
Covid-19 (5)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (6)
Future of Work (2)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)
Internet of Things (2)
Microbiome (1)
Mobile Health (1)
Nanomedicine (2)
Oncology (4)
Orphan Designated Drugs (4)
Other Innovation Areas (87)
Precision and Personalized Medicine (1)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (2)
Small molecules (1)
Smart Hospitals (2)
Social Responsibility (3)
Virtual Care (3)
Showing 3 results out of 3
Q1 2024 update: mentions of virtual care in pharmaceutical industry filings
The global pharmaceutical industry experienced a 73% drop in company filings mentions of virtual care in Q1 2024 compared with...
Q3 2023 update: virtual care related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that virtual care accounted for 3 pharmaceutical deals announced in Q3...
Who’s posting what? Virtual Care related social media posts increased by 21% in the pharma industry in Q1 2023
The global pharma industry experienced a 21% rise in social media posts on virtual care in Q1 2023 compared with...